Johnson & Johnson (Vietnam) Co., Ltd. has formalized a collaboration with the National Hospital of Dermatology and Venereology (NHDV) and the Ho Chi Minh City Hospital of Dermato‑Venereology (HHDV), with focus on three pillars — Advancing Psoriasis Care, Enabling Patient‑Centric Innovation, and Building Professional Leadership — to enhance disease awareness, optimize care pathways, and ultimately improve treatment outcomes for a better quality of life for patients. As part of this collaborative effort, Johnson & Johnson Vietnam has also introduced a public psoriasis awareness display at both hospitals, bringing to life the experiences of nearly 300,000 Vietnamese adults living with psoriasis and helping to foster greater understanding and empathy toward the condition.
Johnson & Johnson (Vietnam) Co., Ltd. (“Johnson & Johnson Vietnam”) continues to advance its long‑term commitment to improving standards of patient care across a broad range of disease areas in Vietnam. Moving to 2026, the Company is deepening this mission through new formalized partnerships, marking a renewed focus on strengthening support for people living with psoriasis. Through this collaboration, Johnson & Johnson Vietnam aims to enhance disease awareness, drive access to innovative therapies, and build scientific capabilities in hospitals.
Psoriasis: A Disease still widely misunderstood in Vietnam
Psoriasis is a chronic, immune-mediated inflammatory disease that extends far beyond visible skin symptoms, yet it remains under-recognized in Vietnam. Commonly perceived as a minor dermatological issue, psoriasis is often misunderstood as a short-term or cosmetic condition, leading to delayed diagnosis and fragmented care – particularly for patients with moderate to severe disease.
In Vietnam, an estimated 288,580 adults are living with psoriasis, representing approximately 0.3% of the adult population. The disease can affect multiple parts of the body, including the scalp, face, nails, palms, soles, and other sensitive areas, significantly affecting daily activities, self-esteem, and social interactions. Beyond physical discomfort, people living with psoriasis frequently experience psychological distress and reduced quality of life due to stigma and misunderstanding.
One of the most persistent misconceptions surrounding psoriasis is the belief that it is merely a skin condition—and even worse, that it is contagious. These misunderstandings fuel social stigma and isolation, discourage individuals from seeking early medical advice, and contribute to the neglect of important comorbidities and mental‑health needs. Access to advanced therapies remains limited, and comprehensive, multidisciplinary management is still difficult to achieve across regions. Addressing these challenges in public is essential to encourage timely consultation, support earlier diagnosis, and improve care pathways for people living with psoriasis in Vietnam.
Strengthening psoriasis care pathways through partnership and education
Recognizing disease awareness and clinical standardization as critical foundations for improving psoriasis care, Johnson & Johnson Vietnam is partnering with the National Hospital of Dermatology and Venereology and the Ho Chi Minh City Hospital of Dermato‑Venereology under three pillars – Advancing Psoriasis Care, Patient‑Centric Innovation, and Professional Leadership – to raise care quality, expand patient support, strengthen public understanding, and reinforce dermatology leadership in shaping national standards. This framework aligns clinical practice, enables earlier, more informed awareness along the care pathway, and advances a coordinated, patient‑focused model for psoriasis management in Vietnam.
As the first milestone of strengthening public understanding, Johnson & Johnson Vietnam has hosted a psoriasis disease awareness display at both partnering hospitals from January 26th to February 8th, 2026. Designed as a patient-centric educational space, the display highlights real patient stories and gently addresses common misconceptions – especially the belief that psoriasis is contagious. Beyond raising awareness, the display also conveys an important message: psoriasis is a condition that can be well controlled and effectively managed with the right treatment approach. Through this effort, the initiative encourages earlier consultation with healthcare professionals, supports more informed patient decision-making, and fosters greater empathy toward individuals living with psoriasis.
Mr. Upendra Patkie, General Manager of Johnson & Johnson Innovative Medicine Vietnam, shared: “Our collaborations with the National Hospital of Dermatology and Venereology and the Ho Chi Minh City Hospital of Dermato‑Venereology are grounded in a shared vision and commitment to Advancing Psoriasis Care in Vietnam. Through improved education and more consistent clinical practices, we aim to support earlier and more accurate diagnosis of psoriasis and help expand access to appropriate treatment for patients. We believe that our public awareness initiatives will amplify real patient stories, shift societal perceptions, and encourage people to seek care earlier and with greater confidence. Together, these initiatives strengthen the capabilities of healthcare professionals, enhance the treatment experience for families, and move us closer to a more compassionate, patient‑focused psoriasis care pathway. This reflects J&J’s continued commitment to putting patients first.”
Discover more from Vietnam Insider
Subscribe to get the latest posts sent to your email.